4-butyrolactone has been researched along with 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chagraoui, A; Protais, P; Vasse, M | 1 |
| Barbanel, G; Maurice, T; Vignon, J | 1 |
2 other study(ies) available for 4-butyrolactone and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine
| Article | Year |
|---|---|
Interaction of amineptine with agents modifying dopaminergic transmission.
Topics: 4-Butyrolactone; Animals; Antidepressive Agents, Tricyclic; Dextroamphetamine; Dibenzocycloheptenes; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Male; Mice; Motor Activity; Piperazines; Reserpine; Synaptic Transmission | 1989 |
Endogenous dopamine differently affects N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine and cocaine binding to the dopamine uptake complex.
Topics: 4-Butyrolactone; Animals; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Male; Membrane Proteins; Mice; Nerve Tissue Proteins; Phencyclidine; Piperazines | 1993 |